Adipose-derived mesenchymal stem cells-derived exosome-mediated microRNA-342-5p protects endothelial cells against

Xiaohui Xing1,2, Zhongchen Li2,3, Xin Yang4

  • 1Department of Neurosurgery, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan 250000, Shandong Province, P.R. China.

Aging
|February 26, 2020
PubMed

Insights

Adipose-derived mesenchymal stem cell exosomes reduce miR-342-5p levels, protecting against atherosclerosis by inhibiting endothelial cell apoptosis. This study identifies a novel therapeutic pathway for atherosclerosis treatment.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Exosomes mediate microRNAs (miRNAs) influencing disease progression, including atherosclerosis.
  • Understanding miRNA roles in atherosclerosis is crucial for developing targeted therapies.
  • Human umbilical vein endothelial cells (HUVECs) are key players in vascular health and disease.

Purpose of the Study:

  • To screen for atherosclerosis-associated miRNAs.
  • To investigate the regulatory mechanism of atherosclerosis involving identified miRNAs.
  • To explore the protective role of adipose-derived mesenchymal stem cell (ADSC)-derived exosomes.

Main Methods:

  • Construction of a HUVEC lesion model.
  • RNA-sequencing and bioinformatics analyses to identify miRNAs.
  • Overexpression and knockdown experiments for miR-342-5p.
  • Characterization of ADSC-derived exosomes.
  • Assessment of exosome effects on miR-342-5p expression in HUVECs.

Main Results:

  • miR-342-5p was identified as an atherosclerosis-associated miRNA in HUVECs.
  • miR-342-5p modulated HUVEC apoptosis; its target was identified as PPP1R12B.
  • ADSC-derived exosomes decreased miR-342-5p expression in the HUVEC lesion model.

Conclusions:

  • miR-342-5p plays a significant role in endothelial cell apoptosis and atherosclerosis.
  • ADSC-derived exosomes exert protective effects by downregulating miR-342-5p.
  • This study reveals a potential therapeutic mechanism involving exosome-mediated miRNA regulation in atherosclerosis.